Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q1 2020 · 10-Q
Revenue$36.86M$36.86M+68.3% vs Q1 2019 Net Income-$66.36M-$66.36MN/M vs Q1 2019 EPS Diluted-$0.74-$0.74N/M vs Q1 2019 Gross Profit$28,422,000+60.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
Operating Cash Flow-$57,935,000N/M Free Cash Flowderived-$60,614,000N/M Margins · derivedGross margin77.1%−3.9 pt vs Q1 2019
Operating margin-163.7%+153.6 pt vs Q1 2019
Net margin-180.0%+158.5 pt vs Q1 2019
ended Mar 31, 2020 · filed Apr 30, 2020 · 30 d after period end